Aptar Pharma Completes First Phase of Global Injectables Expansion Program

The multisite, international expansion project began in 2020 and is intended to significantly boost ...

Aptar Pharma highlights Innovative Drug Delivery Solutions at CPhI Europe

From October 24th to 26th, 2023, in Barcelona, Spain, Aptar Pharma will showcase its diverse portfol...

Aptar Pharma Launches First Metal-Free Highly Recyclable Nasal Spray Pump

Aptar Pharma announces the launch of APF Futurity, its first metal-free, multidose nasal spray pump ...

Aptar acquires Nanopharm and Gateway Analytical, broadening pharma services platform to accelerate customer drug development

AptarGroup, Inc. has announced that it has acquired two leading pharmaceutical services companies, N...

Aptar Pharma co-organizer and diamond sponsor of RDD Europe 2019 conference in Estoril, Portugal

Aptar Pharma, the leader in respiratory drug delivery systems, is proud to announce its co- organiza...

Aptar Pharma to host three insightful Learning Lab sessions

Aptar Pharma will host three insightful Learning Lab sessions on Wednesday, February 5 at Pharmapack...

Aptar Pharma showcases expanded portfolio of respiratory innovations and services

Aptar Pharma has announced its Platinum Sponsorship of this year’s Drug Delivery to the Lung Confere...

Aptar Pharma QuickStart, an injectable device development kit, to launch at CPhI Worldwide

Aptar Pharma, a leading provider of innovative drug delivery systems, in combination with Schott Gla...

Aptar Pharma QuickStart Injectables wins Industry Innovation Award at Pharmapack 2019

Aptar Pharma, a leading provider of innovative drug delivery systems, has announced that their recen...

Aptar Pharma is bringing the respiratory world together

Aptar Pharma is pleased to announce the co-organization and diamond sponsorship of the Respiratory D...

Aptar Pharma showcases PureHale and QuickStartTM Injectables product launches

As part of the Innovation Gallery at Pharmapack this year, Aptar Pharma will showcase two of their n...

Aptar Pharma's Preservative-Free Multidose Dispenser approved for anti-allergy treatment by French regulatory agency ANSM

Aptar Pharma’s innovative, preservative-free multidose Ophthalmic Squeeze Dispenser is the approved ...

Aptar Pharma and RDD Online co-organize the second edition of RDD ASIA in Goa, India

Aptar Pharma and RDD Online today announced the second Respiratory Drug Delivery (RDD®) Asia scienti...

Pulmonary and nasal drug delivery experts to attend RDD Europe 2017

Register now to attend the RDD Europe 2017 Scientific Conference to be held April 25-28, 2017, in A...

Aptar Pharma's Freepod nasal spray device with GlaxoSmithKline's Otrivin wins prestigious WPO WorldStar 2019 award

Aptar Pharma, a leading provider of innovative drug delivery systems, has announced that its patente...

Pulmonary and Nasal Drug Delivery Experts to attend RDD Europe 2017

The Respiratory Drug Delivery (RDD®) Europe 2017 scientific conference will welcome pulmonary and na...

Aptar Pharma's electronic lockout device approved by EMA

Aptar Pharma, a world leader in innovative drug delivery systems, is pleased to announce the approva...

Aptar Pharma's preservative-free multidose dispenser approved across Europe for Santen's Taflotan/Saflutan prescription treatment

Aptar Pharma is pleased to announce that its innovative, preservative-free multidose Ophthalmic Sque...

Aptar Pharma presents a step change in the performance of DF30Plus for pMDIs incorporating COC

Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray deliv...

Aptar Pharma’s Ophthalmic Squeeze Dispenser – Innovation based on experience

Preservatives in eye care products often cause discomfort or even serious side effects. With the Oph...

Aptar Mezzovico

Aptar Le Vaudreuil

Aptar Radolfzell / Aptar Eigeltingen